Developing an adverse drug reaction reporting program
Nelson, R.W.; Shane, R.
American Journal of Hospital Pharmacy 40(3): 445-446
1983
ISSN/ISBN: 0002-9289 PMID: 6846354 Document Number: 197188
Document emailed within 1 workday
Related Documents
Cantú, T.G.; Tyler, L.S. 1988: Development of a hospital-based adverse drug reaction reporting program Hospital Formulary 23(8): 658-661Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Kaplan, A.S. 1984: Adverse drug reaction reporting and the family physician Journal of Family Practice 19(4): 563-564
Juergens, J.P.; Banahan, B.F. 1986: Adverse drug reaction reporting by Mississippi physicians Journal of the Mississippi State Medical Association 27(2): 33-37
Lee, B.; Groth, P.E. 1978: The need for pharmacists' cooperation in national adverse drug reaction reporting Hospital Formulary 13(11): 888-91 895
Prosser, T.R.; Kamysz, P.L. 1990: Multidisciplinary adverse drug reaction surveillance program American Journal of Hospital Pharmacy 47(6): 1334-1339
Chaikoolvatana, A.; Chanakit, T.; Juengrakpong, A. 2006: The evaluation of a recurrent Adverse Drug Reaction Prevention Program in the north-east region of Thailand Journal of the Medical Association of Thailand 89(5): 699-705
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Soletsky, L.M. 1997: Reporting of adverse drug reactions Postgraduate Medicine 102(1): 35-36
Kimelblatt, B.J.; Young, S.H.; Heywood, P.M.; Mandala, A.R.; Gendelman, S.; Mehl, B. 1988: Improved reporting of adverse drug reactions American Journal of Hospital Pharmacy 45(5): 1086-1089
Venulet, J. 1992: Establishing requirements for the use of terms for reporting adverse drug reactions International Journal of Clinical Pharmacology Research 12(2): 61-64
Bégaud, B.; Martin, K.; Haramburu, Fçoise.; Moore, N. 2002: Rates of spontaneous reporting of adverse drug reactions in France JAMA 288(13): 1588
Schetz, D.; Sein Anand, J. 2015: Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region Przeglad Lekarski 72(9): 475-478
Kalaiselvan, V.; Prasad, T.; Bisht, A.; Singh, S.; Singh, G.Nath. 2014: Adverse drug reactions reporting culture in Pharmacovigilance Programme of India Indian Journal of Medical Research 140(4): 563-564
Schumock, G.T.; Thornton, J.P.; Witte, K.W. 1991: Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions American Journal of Hospital Pharmacy 48(9): 1974-1976
Gram, L.F. 1995: Attitude and considerations of Danish physicians towards reporting of adverse drug reactions--a questionnaire study under European direction Ugeskrift for Laeger 157(12): 1692-1694
Perman, E. 1999: More and more tooth injuries are being reported to the Läkemedelsförsökring (Drug Reaction Reporting System) Lakartidningen 96(14): 1767